It takes more than a single target
As the challenges you face evolve, stay one step ahead with cobas® HIV-1 for use on the cobas® 6800/8800 Systems, a next-generation, dual-target quantitative HIV-1 assay, only from Roche.
The cobas® HIV-1 quantitative nucleic acid test for use on the cobas® 6800/8800 Systems targets two unique regions of the HIV-1 genome to improve genotype inclusivity, detect HIV-1 variants and potentially avoid under quantification. The rapidly mutating HIV-1 virus can evade quantification with a single-target, viral-load assay.1,2
Get dual-target reliability for HIV-1 quantification
Roche dual-target assays provide reliable results to confidently and effectively quantify HIV-1 with improved test sensitivity, coverage and security.
- Target two unique regions of the HIV-1 genome, gag and LTR, which are not subject to selective drug pressure
- Confidently detect HIV-1 variants and potentially avoid under quantification
- Accurately quantify HIV-1 RNA with a dual-target assay and contribute to optimal treatment decisions for patient management